Cayman Pharma

(±)-Cloprostenol (sodium salt)

• Printable view (±)-Cloprostenol (sodium salt)
Assay (as per BVP 2002) 97.5 - 101.0% abs.
Impurities total (as per BVP 2002) max. 2.0% abs.
Purity (HPLC)
(±)-Cloprostenol min. 98.0% rel.
15S-(±)-cloprostenol max. 0.5% rel.
5,6-trans-(±)-cloprostenol max. 1.0% rel.
Other impurities single max. 0.1% rel.
Other impurities total max. 0.4% rel.
Water max. 3.0% abs

Product quality complies with USP XXVI and EP 2002 for category 2 and 3A of non-sterile products. Complete specification is available upon request.

(+420) 315 664 387
Cayman Pharma. s r.o.
ul. Práce 657
277 11 Neratovice
All contact information
© 2010 Cayman Pharma